Suboxone & buprenorphine: Addiction treatment with a dark side
from The New York Times
Surpassing well-known medications like Viagra and Adderall, Suboxone generated $1.55 billion in United States sales last year, its success fueled by the embrace of federal officials who helped finance its development and promoted it as a safer, less stigmatized alternative to methadone. But more than a decade after Suboxone went on the market, and with the Affordable Care Act poised to bring many more addicts into treatment, the high hopes have been tempered by a messy reality. Suboxone and its primary ingredient, buprenorphine, have become both medication and dope: a treatment with considerable successes and also failures, as well as a street and prison drug bedeviling local authorities. It has attracted unscrupulous doctors and caused more health complications and deaths than its advocates acknowledge.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063